《现代医学与健康研究》编辑部官网!【中国医师协会系列期刊】
健脾益肾汤联合坦索罗辛在良性前列腺增生患者治疗中的应用研究
DOI:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R697+.32

基金项目:


Application of Jianpi Yishen Decoction combined with Tamsulosin in the treatment of patients with benign prostatic hyperplasia
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨健脾益肾汤联合坦索罗辛对良性前列腺增生患者下尿路症状与血清白细胞介素 -6(IL-6)、肿瘤坏死因子 -α(TNF-α)、前列腺特异抗原(PSA)水平的影响。方法 按照随机数字表法将昆山市中医医院 2019 年 2 月至 2021 年 2 月收治的 62 例良性前列腺增生患者分为对照组与观察组,每组31例。给予对照组患者盐酸坦索罗辛缓释胶囊,观察组患者在对照组的基础上联合健脾益肾汤进行治疗,两组患者治疗周期均为3个月。将两组患者治疗后临床疗效,治疗前后中医证候积分、国际前列腺症状评分(I-PSS)、生活质量评分(QOL)、残余尿量(PVR)、平均尿流率(Qave)、最大尿流率(Qmax)、前列腺体积,以及血清 TNF-α、IL-6、PSA 水平进行比较。结果 治疗后,观察组患者临床总有效率为 90.31%,高于对照组的 67.74%;与治疗前比,治疗后两组患者小便不利、无力排出、夜尿频多、尿线细弱、畏寒肢冷、舌淡苔腻等中医证候积分,I-PSS、QOL 评分、PVR 及血清 TNF-α、IL-6、PSA 水平均降低,且观察组低于对照组;与治疗前比,治疗后两组患者前列腺体积均缩小,且观察组小于对照组;治疗后,两组患者 Qave、Qmax 均较治疗前升高,且观察组高于对照组(均P < 0.05)。结论 健脾益肾汤联合坦索罗辛可有效改善良性前列腺增生患者临床症状,缩小前列腺体积,改善患者泌尿系统生理功能,进而降低急性尿潴留的发生率,同时可降低机体内炎性因子与 PSA 水平,提高患者生活质量。

    Abstract:

    Objective To investigate the effects of Jianpi Yishen Decoction combined with Tamsulosin on lower urinary tract symptoms and serum interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α) and prostate specific antigen (PSA) levels in patients with benign prostatic hyperplasia. Methods 62 cases patients with benign prostatic hyperplasia admitted to Kunshan Hospital of Traditional Chinese Medicine from February 2019 to February 2021 were divided into the control group and the observation group according to the random number table method, with 31 cases in each group. The patients in the control group were given Tamsulosin Hydrochloride sustained-release capsules, and the patients in the observation group were treated with Jianpi Yishen Decoction on the basis of the control group. The treatment period of the two groups was 3 months. The clinical efficacy of patients in the two groups after treatment, syndrome score of traditional Chinese medicine before and after treatment, international prostate symptom score (I-PSS), quality of life score (QOL), post-voiding residual (PVR), average flow rate (Qave), the maximum flow rate (Qmax), prostate volume, and serum TNF-α, IL-6, and PSA levels of patients in the two groups were compared. Results After treatment, the total clinical effective rate of patients in the observation group was 90.31%, which was higher than 67.74% in the control group; compared with before treatment, the syndrome scores of traditional Chinese medicine of dysuria, inability to discharge, nocturnal frequent urination, weak urinary line, chills and cold limbs, light tongue and greasy coating and I-PSS, QOL score, PVR,and serum TNF-α, IL-6, PSA levels decreased, and the observation group was lower than the control group; compared with before treatment, the prostate volume of patients in the two groups reduced, and the observation group was smaller than the control group. After treatment, the Qave and Qmax of patients in the two groups were higher than before treatment, and the observation group was higher than the control group (all P<0.05). Conclusion Jianpi Yishen Decoction combined with Tamsulosin can effectively improve the clinical symptoms of patients with benign prostatic hyperplasia, reduce the the prostate volume, improve the physiological function of the patients’ urinary system, thereby reducing the incidence of acute urinary retention, and at the same time can reduce the body's inflammatory factors and PSA levels, improve the quality of life of patients

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-08-26
  • 出版日期:

地址:北京朝阳区北沙滩1号16信箱

邮编:100083

电话:010-64882183 64883630

E-mail:xdyx2020@vip.163.com


温馨提示:建议您使用Chrome80、火狐74+、IE11浏览器 ,当您的浏览器版本过低,可能会影响部分功能正常使用。

现代医学与健康研究 ® 2024 版权所有

技术支持:北京勤云科技发展有限公司